Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,197Revenue $M578Net Margin (%)19.8Z-Score7.7
Enterprise Value $M1,858EPS $1.6Operating Margin %18.2F-Score5
P/E(ttm))20.4Cash Flow Per Share $1.6Pre-tax Margin (%)23.9Higher ROA y-yY
Price/Book3.210-y EBITDA Growth Rate %0Quick Ratio2.6Cash flow > EarningsY
Price/Sales3.85-y EBITDA Growth Rate %19.1Current Ratio2.8Lower Leverage y-yN
Price/Cash Flow9.5y-y EBITDA Growth Rate %20.6ROA % (ttm)12.1Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)15.6Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M71.4ROI % (ttm)14.8Gross Margin Increase y-yN

Gurus Latest Trades with WX

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
WXRon Baron 2014-03-31 Add0.01%$32.58 - $39.86
($36.74)
$ 31.8-13%Add 25.9%210,500
WXJohn Hussman 2014-03-31 Sold Out -0.03%$32.58 - $39.86
($36.68)
$ 31.8-13%Sold Out0
WXRon Baron 2013-12-31 Add0.02%$26.52 - $38
($31.52)
$ 31.81%Add 883.53%167,200
WXMario Gabelli 2013-12-31 Reduce$26.52 - $38
($31.52)
$ 31.81%Reduce -24.71%65,200
WXJulian Robertson 2013-12-31 Sold Out -2.4%$26.52 - $38
($31.52)
$ 31.81%Sold Out0
WXJohn Hussman 2013-12-31 Reduce-0.02%$26.52 - $38
($31.52)
$ 31.81%Reduce -50%10,000
WXMario Gabelli 2013-09-30 Reduce$20.23 - $28.48
($23.68)
$ 31.834%Reduce -26.05%86,600
WXRon Baron 2013-09-30 Add$20.23 - $28.48
($23.68)
$ 31.834%Add 54.55%17,000
WXJulian Robertson 2013-09-30 Reduce-0.85%$20.23 - $28.48
($23.68)
$ 31.834%Reduce -35.37%576,218
WXJohn Hussman 2013-09-30 Reduce-0.02%$20.23 - $28.48
($23.68)
$ 31.834%Reduce -50%20,000
WXRon Baron 2013-06-30 Buy $16.94 - $21.54
($19.52)
$ 31.863%New holding, 11000 sh.11,000
WXJulian Robertson 2013-06-30 Reduce-0.34%$16.94 - $21.54
($19.52)
$ 31.863%Reduce -13.99%891,618
WXJohn Hussman 2013-03-31 Buy 0.03%$15.44 - $17.91
($16.53)
$ 31.892%New holding, 40000 sh.40,000
WXJulian Robertson 2012-06-30 Add0.28%$13.37 - $14.84
($14.21)
$ 31.8124%Add 6.51%1,154,418
WXJulian Robertson 2012-03-31 Reduce-1.67%$11.43 - $15.39
($12.73)
$ 31.8150%Reduce -24.88%1,083,818
WXMario Gabelli 2011-12-31 Reduce-0.01%$10.78 - $13.92
($11.9)
$ 31.8167%Reduce -28.82%250,200
WXJulian Robertson 2011-09-30 Add1.9%$11.56 - $17.26
($14.19)
$ 31.8124%Add 38.6%1,442,806
WXGeorge Soros 2011-06-30 Sold Out $16 - $18.89
($17.29)
$ 31.884%Sold Out0
WXJulian Robertson 2011-03-31 Add0.24%$15.07 - $18.49
($16.38)
$ 31.894%Add 5.71%1,095,772
WXGeorge Soros 2011-03-31 Buy 0.05%$15.07 - $18.49
($16.38)
$ 31.894%New holding, 250000 sh.250,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

WX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
WX Ron Baron 2014-03-31210,5000.290.03+25.9%
WX Mario Gabelli 2014-03-3159,7000.080.01-8.44%
WX John Hussman 2014-03-31000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


WX: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about WX :

    Quarterly/Annual Reports about WX:

      News about WX:

      Articles On GuruFocus.com
      Baron Funds Comments on WuXi PharmaTech Feb 24 2014 
      Columbia Management's Top 5 New Buys Amid Buoyant Outlook Aug 12 2013 
      comment on WX Sep 15 2012 
      Stocks That Are Cheaper Than Julian Robertson Bought Jan 06 2012 
      Stocks That Julian Robertson Keeps Buying Dec 23 2011 
      Julian Robertson’s "smart idea, grounded on exhaustive research, followed by a big bet" Jun 24 2011 
      Julian Robertson’s Tiger Management Q1 Portfolio Update May 16 2011 
      Tiger Management Buys WX, CVC, THRX, Sells Apple Inc., Google Inc., Ebay Inc. Nov 15 2010 
      WuXi PharmaTech Will Focus U.S. Operations on Laboratory Testing Services Dec 09 2008 


      More From Other Websites
      WuXi PharmaTech Schedules Second-Quarter 2014 Earnings Release Jul 22 2014
      WuXi PharmaTech Schedules Second-Quarter 2014 Earnings Release Jul 22 2014
      Week In Review: Luye Pharma Completes Successful IPO In Hong Kong Jul 14 2014
      Director Ying Han Resigns from WuXi Board Jul 08 2014
      Director Ying Han Resigns from WuXi Board Jul 08 2014
      5 Foreign Stocks You Need to Sell This Summer Jul 01 2014
      WuXi AppTec Webinar on Breakthrough Drugs Draws Strong Attendance Jun 23 2014
      WuXi PharmaTech Toxicology Facility in Suzhou Passes FDA Inspection Jun 20 2014
      Trade-Ideas: WuXi PharmaTech (WX) Is Today's "Dead Cat Bounce" Stock Jun 16 2014
      WuXi PharmaTech (WX) in Focus: Stock Falls 6.4% Jun 16 2014
      Survey Shows Strong Potential In Healthcare May 30 2014
      WuXi PharmaTech begins operation of new high-potency API laboratory May 28 2014
      WuXi PharmaTech Begins Operation of New High-Potency API Laboratory May 28 2014
      Targos Molecular Pathology GmbH and WuXi PharmaTech to Collaborate in Clinical Biomarker Services... May 23 2014
      Stocks Buck Headwinds To Finish Higher May 22 2014
      WuXi PharmaTech Toxicology Facility in Suzhou Passes OECD GLP Inspection May 21 2014
      Stocks Down In Afternoon As Solar Stocks Keep Sliding May 16 2014
      Stocks Close Off Day's Lows; Vipshop Jumps May 15 2014
      Stocks Down In Afternoon; HollySys Triggers Sell Rule May 15 2014

      Add Notes, Comments or Ask Questions

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK
      Email Hide